SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weissman MM, Bland RC, Canino GJ et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J. Clin. Psychiatry 1994; 55: 510.
  • 2
    Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006; 146: 137147.
  • 3
    Russell A, Cortese B, Lorch E et al. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J. Child Adolesc. Psychopharmacol. 2003; 13: S31S38.
  • 4
    Jang JH, Kwon JS, Jang DP et al. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naïve patients with obsessive-compulsive disorder. Am. J. Psychiatry 2006; 163: 12021207.
  • 5
    Ebert D, Speck O, Konig A, Berger M, Hennig J, Hohagen F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res. 1997; 74: 173176.
  • 6
    Sumitani S, Harada M, Kubo H, Ohmori T. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res. 2007; 154: 8592.
  • 7
    Rosenberg DR, Mirza Y, Russell A et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J. Am. Acad. Child Adolesc. Psychiatry 2004; 43: 11461153.
  • 8
    Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J. Am. Acad. Child Adolesc. Psychiatry 2000; 39: 10961103.
  • 9
    Bartha R, Stein MB, Williamson PC et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am. J. Psychiatry 1998; 155: 15841591.
  • 10
    Ohara K, Isoda H, Suzuki Y et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res. 1999; 92: 8391.
  • 11
    Mirza Y, O'Neill J, Smith EA et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J. Child Neurol. 2006; 21: 106111.
  • 12
    Smith EA, Russell A, Lorch E et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol. Psychiatry 2003; 54: 13991405.
  • 13
    Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol. Psychiatry 2000; 47: 174182.
  • 14
    Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J. Child Neurol. 2001; 16: 636641.
  • 15
    Aouizerate B, Guehl D, Cuny E et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog. Neurobiol. 2004; 72: 195221.
  • 16
    Friedlander L, Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin. Psychol. Rev. 2006; 26: 3249.
  • 17
    Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998; 59: 2233.
  • 18
    Sheehan DV, Lecrubier Y, Sheehan KH et al. The validity of the Mini International Neuropsychiatric Interview (MINI)according to the SCID-P and its reliability. Eur. Psychiatry 1997; 12: 232241.
  • 19
    Si TM, Shu L, Dang WM et al. Evaluation of the reliability and validity of Chinese version of the Mini-International Neuropsychiatric Interview in patients with mental disorders. Chin. Ment. Health J. 2009; 23: 493497.
  • 20
    Goodman WK, Price LH, Rasmussen SA et al. The Yale–Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch. Gen. Psychiatry 1989; 46: 10061011.
  • 21
    Xu Y, Zhang H. The reliability and validity of the Chinese version of Yale-Brown obsessive-compulsive scale. Shanghai Arch. Psychiatry 2006; 18: 321323.
  • 22
    Shear MK, Bilt JV, Rucci P et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress. Anxiety 2001; 13: 166178.
  • 23
    Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch. Gen. Psychiatry 1988; 45: 742747.
  • 24
    Spielberger CD, Diaz-Guerrero R (eds). Cross-Cultural Anxiety. (Vol. 2). Hemisphere, Washington D.C., 1983.
  • 25
    Rosenberg DR, Keshavan MS. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol. Psychiatry 1998; 43: 623640.
  • 26
    Grachev ID, Apkarian AV. Anxiety in healthy humans is associated with orbital frontal chemistry. Mol. Psychiatry 2000; 5: 482488.
  • 27
    Kitamura H, Shioiri T, Kimura T, Ohkubo M, Nakada T, Someya T. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-Tesla. Acta Psychiatr. Scand. 2006; 114: 101108.